jason leitch, as we are looking — there to jason leitch, as we are looking at— there to jason leitchcing about one _ the uk, we are routinely sequencing about one in — the uk, we are routinely sequencing about one in five, _ the uk, we are routinely sequencing about one in five, 20%, _ the uk, we are routinely sequencing about one in five, 20%, but- the uk, we are routinely sequencing about one in five, 20%, but all- the uk, we are routinely sequencing about one in five, 20%, but all of. about one in five, 20%, but all of these _ about one in five, 20%, but all of these s— about one in five, 20%, but all of these s gene _ about one in five, 20%, but all of these s gene dropout _ about one in five, 20%, but all of these s gene dropout cases- about one in five, 20%, but all of these s gene dropout cases now, about one in five, 20%, but all of- these s gene dropout cases now, when we have _ these s gene dropout cases now, when we have manageable _ these s gene dropout cases now, when we have manageable numbers, - these s gene dropout cases now, when we have manageable numbers, will. the